An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for REGENERON PHARMACEUTICALS
| Ticker | REGN |
| FIGI | BBG000C734W3 |
| CUSIP | 75886F107 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 1263 / 18.0% |
| Percentage held by institutional investors | 89.6% |
About
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia